Stockscreener 앱 받기
4.9498
0.40%
0.0198
Precision Biosciences Inc 주식(DTIL)의 최신 뉴스
Brown Melinda buys $6846 in Precision BioSciences (DTIL) By Investing.com - Investing.com Nigeria
Brown Melinda buys $6846 in Precision BioSciences (DTIL) - Investing.com India
Insider Buying: Melinda Brown Acquires Shares in Precision BioSc - GuruFocus
Risk Recap: How does Precision BioSciences Inc correlate with Nasdaq2025 Technical Overview & Precise Swing Trade Alerts - خودرو بانک
Layoff Tracker: Arvinas Downsizes by 15% After Punting Pfizer-Partnered Asset - BioSpace
Candlestick signals on Precision BioSciences Inc. stock today2025 Year in Review & Growth Oriented Trade Recommendations - newser.com
Published on: 2025-09-18 07:24:27 - newser.com
Precision BioSciences (DTIL) Reports Q4 Loss, Misses Revenue Estimates - MSN
AI Stocks: What is the long term forecast for Precision BioSciences Inc. stockWeekly Profit Report & Long-Term Capital Growth Strategies - خودرو بانک
ARCUS Gene Editor Shows Promise Against Hepatitis B - CRISPR Medicine News
Surprises Report: Is Precision BioSciences Inc stock trending bullish2025 Momentum Check & Target Return Focused Picks - خودرو بانک
Insider Buy: Whats the outlook for Precision BioSciences Incs sectorJuly 2025 Pullbacks & High Conviction Investment Ideas - خودرو بانک
Is Precision BioSciences Inc likely to announce a buyback2025 Market Trends & Reliable Intraday Trade Alerts - خودرو بانک
Published on: 2025-09-16 12:16:08 - newser.com
Is Precision BioSciences Inc. building a consolidation baseTrade Analysis Summary & Free Fast Gain Swing Trade Alerts - newser.com
Nasdaq Moves: What is the long term forecast for Precision BioSciences Inc stockStop Loss & Weekly Market Pulse Alerts - خودرو بانک
Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial of PBGENE-HBV at the 6th International Coalition to Eliminate HBV Cure Symposium - BioSpace
Transcript : Precision BioSciences, Inc. Presents at H.C. Wainwright 27th Annual Global Investment Conference, Sep-09-2025 10 - MarketScreener
Sectors Review: Is Precision BioSciences Inc a speculative investmentJuly 2025 Snapshot & Real-Time Volume Trigger Notifications - خودرو بانک
What momentum shifts mean for Precision BioSciences Inc.Take Profit & Weekly High Potential Alerts - newser.com
Stock Analysis: Does BNTX offer margin of safetyPortfolio Update Summary & Stock Portfolio Risk Management - خودرو بانک
Smart tools for monitoring Precision BioSciences Inc.’s price actionMarket Sentiment Review & Technical Entry and Exit Alerts - newser.com
Reversal indicators forming on Precision BioSciences Inc. stockPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
How to integrate Precision BioSciences Inc. into portfolio analysis tools2025 Valuation Update & Stepwise Entry and Exit Trade Signals - newser.com
When is the best time to exit Precision BioSciences Inc.M&A Rumor & AI Based Trade Execution Alerts - newser.com
Precision BioSciences Inc. stock volume spike explainedWatch List & Safe Entry Point Identification - newser.com
What MACD signals say about Precision BioSciences Inc.July 2025 Trends & Community Verified Trade Signals - newser.com
Precision BioSciences presents data from hepatitis B gene editing trial By Investing.com - Investing.com Australia
Can Precision BioSciences Inc. hit a new high this monthGlobal Markets & Free High Return Stock Watch Alerts - Newser
Is Precision BioSciences Inc. stock poised for growthWeekly Gains Report & Reliable Volume Spike Trade Alerts - Newser
Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial - Contract Pharma
Will Precision BioSciences Inc. bounce back from current supportTreasury Yields & AI Powered Market Entry Strategies - Newser
Custom strategy builders for tracking Precision BioSciences Inc.July 2025 PostEarnings & High Return Trade Opportunity Guides - Newser
Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial of PBGENE-HBV at the 6th Inte - PharmiWeb.com
Precision BioSciences presents phase 1 PBGENE-HBV trial data at HBV Cure Symposium; targets chronic hepatitis B - MarketScreener
Precision BioSciences presents data from hepatitis B gene editing trial - Investing.com
Statistical indicators supporting Precision BioSciences Inc.’s strengthJuly 2025 Chart Watch & Advanced Technical Analysis Signals - Newser
Risk adjusted return profile for Precision BioSciences Inc. analyzedJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - Newser
Will Precision BioSciences Inc. price bounce be sustainableTrade Entry Report & Reliable Price Breakout Signals - Newser
Top chart patterns to watch in Precision BioSciences Inc.July 2025 Highlights & Reliable Breakout Forecasts - Newser
Will Precision BioSciences Inc. continue its uptrendEarnings Overview Report & Daily Profit Maximizing Trade Tips - Newser
What MACD and RSI say about Precision BioSciences Inc.2025 Biggest Moves & Real-Time Sentiment Analysis - Newser
Comparing Precision BioSciences Inc. in custom built stock radarsMarket Growth Review & Free AI Powered Buy and Sell Recommendations - Newser
4.19%
0.83%
자본화:
|
볼륨(24시간):